🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Lotus Clinical Research
Start Date
2009-11
Trial ID
NCT01014650
Treatments Being Tested
Based on the pharmacological class of rapastinel, this study will be conduc...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2018-11-05
Trial ID
NCT03814733
This study will evaluate the efficacy, safety, and tolerability of two dose...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-11-01
Trial ID
NCT02943564
Treatments Being Tested
The purpose of this study is to determine whether GLYX-13 reduces depressio...
Status
Completed
Location
Mulitple
Start Date
2011-05
Trial ID
NCT01234558
Treatments Being Tested
This study will evaluate the efficacy, safety and tolerability of rapastine...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-11-13
Trial ID
NCT02951988
Treatments Being Tested
The present study proposes to evaluate the potential cognitive enhancing ef...
Status
Terminated
Location
Northwestern University
Start Date
2013-05
Trial ID
NCT01844726
This research study tests whether GLYX-13 - an experimental drug that acts ...
Status
Completed
Location
New York State Psychiatric Insitute
Start Date
2014-10
Trial ID
NCT02267629
Treatments Being Tested
This study will evaluate the long-term safety and tolerability of rapastine...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-02-03
Trial ID
NCT03002077
Treatments Being Tested
This study will evaluate the efficacy, safety, and tolerability of rapastin...
Status
Completed
Location
Southern California Research LLC.
Start Date
2016-10-15
Trial ID
NCT02932943
Treatments Being Tested
The study will evaluate the efficacy, safety, and tolerability of 450 milli...
Status
Terminated
Location
The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
Start Date
2017-12-15
Trial ID
NCT03352453
Treatments Being Tested